Lymphoproliferative disorders in renal transplant patients in Japan

International Journal of Cancer

Volumn 91, Issue 6, 2001, Pages 869-875

  Hoshida, Yoshihiko ^a,b   Li, Ting ^a   Dong, Zhiming ^a   Tomita, Yasuhiko ^a   Yamauchi, Amane ^a   Hanai, Jun ^b   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b SAKAI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Adult T cell lymphoma; Epstein Barr virus; Hemodialysis; Lymphoproliferative disorders; Renal transplantation

Indexed keywords

ADULT; ARTICLE; B CELL LYMPHOMA; BLOOD TRANSFUSION; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HEMODIALYSIS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTIOUS COMPLICATION; JAPAN; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SOUTHERN BLOTTING; SUPERINFECTION; T CELL LYMPHOMA; VIRUS INFECTION;

ADOLESCENT; ADULT; DNA PRIMERS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; KIDNEY TRANSPLANTATION; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RENAL DIALYSIS;

EID: 0035869672     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1125>3.0.CO;2-N     Document Type: Article

References (45)

1. Malignant lymphomas in transplantation patients
2. AIDS-associated non-Hodgkin's lymphoma
3. Epstein-Barr virus and a cellular signalling pathway in lymphomas from immunosuppressed patients
4. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: Implications for down-regulation of HLA-A11 in Burkitt lymphoma
5. Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies
6. HLA A 2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2
7. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease
8. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation
9. Posttransplant lymphoproliferative disorders: Summary of society for hematopathology workshop
10. The changing pattern of posttransplantation malignancies
11. Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients
12. Statistical analysis of clinico-pathological, virological, and epidemiological data on lymphoid malignancies with special reference to adult T-cell leukemia/lymphoma: A report of the second nationwide study of Japan
13. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma
14. Isolation and characterization of retrovirus (ATLV) from cell line of human adult T-cell leukemia and its implication in the disease
15. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
16. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immuno-peroxidase technics
17. Epstein-Barr virus and Hodgkin's disease: A correlative in situ hybridization and polymerase chain reaction study
18. Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms
19. DNA extraction by sonication: A comparison of fresh, frozen, and paraffin-embedded tissues extracted for use in polymerase chain reaction assays
20. Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization
21. Enzymatic amplification of HTLV-1 viral sequences from peripheral blood mononuclear cells and infected tissues
22. Characterization of a sequence of human T-cell leukemia virus type I from a patient with chronic progressive myelopathy
23. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma
24. Non-parametric estimation from incomplete observations
25. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
26. Regression models and life-tables
27. Cancer risk after renal transplantation in Japan
28. A study of the quality of life and cost-utility of renal transplantation
29. Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center
30. HTLV-1 T cell lymphoma in a cyclosporine-treated renal transplant patient
31. FK506 and cyclosporine a regulate proliferation and proto-oncogene expression in HTLV-1-associated myelopathy/tropicalspastic-paraparesis-derived T cells
32. HTLV-1-seronegative, genome-positive adult T cell leukemia: Report of a case
33. Transfusion and long-term hemodialysis
34. Effect of HLA matching in 10,000 cyclosporine-treated cadaver kidney transplants
35. Human T-cell leukemia virus type I infection in hemodialysis patients
36. Prevalence of four blood-borne viruses (HBV, HCV, HTL-1, HIV) among haemodialysis patients in Japan
37. Transfusion transmitted infection of HTLV-1 and its prevention
38. T cell recognition of Epstein-Barr virus associated lymphomas
39. The association of Epstein-Barr virus (EBV) with T-cell lymphoproliferations and Hodgkin's disease: Two new developments in the EBV field
40. Epstein-Barr virus in adult T-cell leukemia/lymphoma
41. Natural killer-like T-cell lymphomas: Aggressive lymphomas of T-large granular lymphocytes
42. Post-transplantation lymphoproliferative disorder of the NK-cell type: A case report and review of the literature
43. Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation
44. HLA antigens in Japanese population
45. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups